Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
172
days
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
AuthorsBurak Kundakci; Megan R. W. Barber; Ann E. Clarke; Sindhu R. Johnson; Anselm Mak; Hermine I. Brunner; Murat Inanc; Rosalind Ramsey‐Goldman; Guillermo Ruiz‐Irastorza; Ellen M. Ginzler; John G. Hanly; Alexandra Legge; Cynthia Aranow; Laurent Arnaud; Nathalie Costedoat‐Chalumeau; Dafna D. Gladman; Søren Jacobsen; Michelle Petri; Clovis A. Silva; Évelyne Vinet; Alexandre E. Voskuyl; SDI Revision Literature Review Groups; SDI Revision Delphi Panel; SDI Revision Item Reduction Committee; SDI Revision Clinical Domain Groups; Ian N. Bruce
Affiliations1. Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health The University of Manchester Manchester UK; 2. School of Medicine and Population Health The University of Sheffield Sheffield UK; 3. Division of Rheumatology, Cumming School of Medicine University of Calgary Calgary Alberta Canada; 4. Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute Toronto Western and Mount Sinai Hospitals Toronto Ontario Canada; 5. Institute of Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada; 6. Division of Rheumatology & Allergy, Department of Medicine, Yong Loo Lin School of Medicine National University of Singapore Singapore Republic of Singapore; 7. Department of Pediatrics and Cincinnati Children's Hospital Medical Center University of Cincinnati Cincinnati Ohio; 8. Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty Istanbul University Istanbul Turkey; 9. Department of Medicine/Division of Rheumatology, Feinberg School of Medicine Northwestern University Feinberg School of Medicine Chicago Illinois; 10. Biobizkaia Health Research Institute UPV/EHU‐University of The Basque Country Bizkaia The Basque Country Spain; 11. Rheumatology Division, Department of Medicine State University of New York Downstate Health Sciences University Brooklyn New York New York; 12. Division of Rheumatology, Department of Medicine, Affiliated Scientist, Queen Elizabeth II Health Sciences Center and Nova Scotia Health, Professor Emeritus Dalhousie University Halifax Nova Scotia Canada; 13. Division of Rheumatology, Department of Medicine Dalhousie University Halifax Nova Scotia Canada; 14. Institute of Molecular Medicine, Center for Autoimmune, Musculoskeletal and Hematopoietic Disease, Feinstein Institutes for Medical Research Northwell Health Manhasset New York New York; 15. Department of Rheumatology, National Reference Center for Autoimmune Diseases (RESO), INSERM UMR‐S 1109 Les Hopitaux Universitaires de Strasbourg Strasbourg France; 16. Service de Médecine Interne, Centre de référence des maladies auto‐immunes et auto‐inflammatoires systémiques rares d'Ile‐de‐France, de l'Est et de l'Ouest, Hôpital Cochin, AP‐HP Paris France; 17. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics Paris France; 18. Copenhagen Lupus and Vasculitis Clinic, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark; 19. Division of Rheumatology, Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland; 20. Pediatric Rheumatology Unit Instituto da Criança e do Adolescente, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo Brazil; 21. Divisions of Rheumatology & Clinical Epidemiology, Department of Medicine McGill University Health Centre Montreal Quebec Canada; 22. Department of Rheumatology and Clinical Immunology Amsterdam University Medical Center Amsterdam the Netherlands; 23. Centre for Public Health, Faculty of Medicine, Health and Life Sciences Queen's University Belfast Belfast UK
195
days
Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus
AuthorsShivani Garg; Murray Urowitz; Charlie Dentz; Niriti Adhikari; Fauzia Hollnagel; Nathalie Costedoat‐Chalumeau
Affiliations1. Department of Medicine, Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine Yale University New Haven Connecticut; 2. School of Medicine and Public Health University of Wisconsin‐Madison; 3. Institute of Medical Science University of Toronto Toronto Ontario Canada; 4. Internal Medicine Department, Reference Centre for Rare Autoimmune and Autoinflammatory Diseases Cochin Hospital, Assistance Publique‐Hôpitaux de Paris (AP‐HP); Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics Paris France
72
days
Prevalence of Moderate to Severe Joint Pain Among Adults with Diagnosed Arthritis – United States, 2023
AuthorsElizabeth A. Fallon; Daniel K. White; Fu Zhao; Michael A. Boring; Tyler Lites; Anika Foster; Kamil E. Barbour; Erica L. Odom
Affiliations1. Centers for Disease Control and Prevention, Atlanta Georgia; 2. University of Delaware, Department of Physical Therapy Newark; 3. Chenega Services & Federal Solutions, LLC, Chesapeake Virginia; 4. Oak Ridge Institute for Science and Education Oak Ridge Tennessee; 5. National Institutes of Health Bethesda Maryland
112
days
The Development of Rheumatoid Arthritis‐Specific Ambulatory Care Sensitive Conditions: Results of a Consensus Process
AuthorsKara Irwin; Candace H. Feldman; Claire E.H. Barber; Gabriel Fabreau; Jake Jennings; Scott Patten; Cheryl Barnabe; Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group
Affiliations1. University of Calgary. Calgary Alberta; 2. Harvard Medical School Harvard University and Brigham and Women's Hospital. Boston Massachusetts; 3. Primary Care Alberta. Calgary Alberta
195
days
Clinician and Patient Factors Associated With Long‐Term Glucocorticoid Use in People With Rheumatoid Arthritis Receiving Advanced Therapies
AuthorsMichael D. George; George Reed; Matthew D. Kearney; Peter F. Cronholm; Kevin Kane; Jeffrey R. Curtis; Dimitrios A. Pappas; Joel M. Kremer
Affiliations1. University of Pennsylvania Philadelphia; 2. University of Massachusetts Chan Medical School Worcester; 3. University of Massachusetts Lowell; 4. University of Alabama at Birmingham; 5. Corrona Research Foundation Delray Beach Florida; 6. CorEvitas, LLC Waltham Massachusetts; 7. Columbia University College of Physicians and Surgeons New York City New York
244
days
Long‐Term Lignan Intake, Whole Grain Foods, and the Risk of Gout: Results From Two Prospective Cohort Studies
AuthorsSharan K. Rai; Yang Hu; Ming Ding; Frank B. Hu; Molin Wang; Jorge E. Chavarro; Natalie McCormick; Hyon K. Choi; Qi Sun
Affiliations1. Harvard T. H. Chan School of Public Health, Massachusetts General Hospital, and Harvard Medical School Boston; 2. Harvard T. H. Chan School of Public Health Boston Massachusetts; 3. University of North Carolina at Chapel Hill; 4. Harvard T. H. Chan School of Public Health and Channing Division of Network Medicine Boston Massachusetts; 5. Massachusetts General Hospital and Harvard Medical School Boston; 6. Massachusetts General Hospital, Harvard Medical School, and Channing Division of Network Medicine Boston
273
days
Osteoporotic fracture, diagnostic activity, and treatment in patients with gout
AuthorsEmily E. Holladay; Jingyi Zhang; Fenglong Xie; Angelo Gaffo; Alexis Woods; Shanette Daigle; Brian LaMoreaux; Jeffrey R. Curtis
Affiliations1. University of Alabama at Birmingham Birmingham United States of America; 2. Foundation for Advancing Science, Technology, Education and Research Birmingham United States of America; 3. Amgen Deerfield Illinois United States of America
281
days
Prevalence of Major Pulmonary Complications Among Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta‐Analysis
AuthorsAthanasios Vassilopoulos; Stephanos Vassilopoulos; Markos Kalligeros; Antoun Kamel; Jasneet Singh; Ingrid Lazaridou; Eleftherios Mylonakis; Anthony M. Reginato
Affiliations1. Rhode Island Hospital Warren Alpert Medical School of Brown University Providence RI USA; 2. Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA; 3. University of Texas Southwestern Medical Center Dallas TX USA; 4. Houston Methodist Hospital Houston TX USA
183
days
Preferred Language, Patient‐Provider Interactions and Standardized Outcome Assessment in Patients with Pediatric Rheumatologic Conditions
AuthorsAhmad Bakhsh; Aditi Deokar; Gabrielle Alonzi; Madeline Hlobik; Mia T. Chandler; Edie Weller; Joyce C. Chang
Affiliations1. Department of Pediatrics, Faculty of Medicine University of Jeddah Jeddah Saudi Arabia; 2. Boston Children's Hospital and Harvard Medical School Boston MA USA; 3. Wake Forest University School of Medicine Winston‐Salem NC USA; 4. Biostatistics and Research Design Center, Boston Children's Hospital and Harvard Medical School Boston MA USA
298
days
Factors Associated with Fibromyalgia Diagnosis amongst People Meeting Criteria: Results from UK Biobank
AuthorsSung‐A Kim; Gary J. Macfarlane; Marcus J. Beasley
Affiliations1. Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group) University of Aberdeen Aberdeen United Kingdom; 2. Department of Clinical Korean Medicine, Graduate School Kyung Hee University Seoul South Korea
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days